Altimmune, Inc.
ALT
$2.91
-$0.02-0.68%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.53% | -43.88% | 14.14% | -13.13% | 15.55% |
| Total Depreciation and Amortization | -11.54% | -3.70% | -10.00% | 3.45% | -12.12% |
| Total Amortization of Deferred Charges | -- | -251.33% | 94.83% | -- | -- |
| Total Other Non-Cash Items | -19.11% | 28.83% | 37.82% | -5.09% | 8.89% |
| Change in Net Operating Assets | -155.03% | 2.41% | 1,590.43% | 186.30% | -97.04% |
| Cash from Operations | -7.68% | -63.47% | 38.52% | -14.90% | 7.80% |
| Capital Expenditure | -2,000.00% | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 95.36% | 46.99% | -247.67% | 2,082.30% | -137.42% |
| Cash from Investing | 95.34% | 46.99% | -247.69% | 2,082.10% | -137.42% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 28.57% | 55.39% | 4.87% | 8.33% | 246.17% |
| Repurchase of Common Stock | -2,680.00% | -- | 100.00% | 99.12% | -33,800.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 81.84% | -52.17% | 44.19% | -376.86% | -- |
| Cash from Financing | -3.27% | 106.18% | -24.68% | 53.12% | 238.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 408.09% | 85.66% | -190.95% | 1,000.35% | 123.37% |